Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
NCT04613206Phase 2Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jan 2021
- Primary completion
- Jul 2027
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised trial of influenza virus quadrivalent inactivated vaccine in influenza (3 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Geometric Mean Titers of influenza vaccine antibodies at Day 56 and Number of participants reporting solicited injection site reactions and systemic reactions. Started Jan 2021; status: active, not recruiting.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04613206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613206.